Drug Database
SH

SH-U-454

✓ Approved

Bayer AG · 小分子 · 小分子

什么是 SH-U-454?

SH-U-454 是一种小分子,由Bayer AG研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

公司Bayer AG
药物类别小分子, 影像药物
给药途径Injectable (Others), Intravenous (IV)
状态Approved

治疗适应症

SH-U-454 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Cardiac disordersArteriosclerosis coronary artery✓ Approved

相关研究文献

PubMedGenesis (New York, N.Y. : 2000)2026-08-03

An Efficient Method for Neuron-Like Differentiation of SH-SY5Y Neuroblastoma Cells Using Retinoic Acid and Laminin-Rich Extracellular Matrix.

Grigoli Marina Mantellatto MM, Pachane Bianca Cruz BC, Fuzer Angelina Maria AM, de Oliveira Sabrina Dorta SD et al.

The human neuroblastoma cell line SH-SY5Y is widely used in vitro as a model due to its ability to acquire neuron-like properties. Conventional differentiation protocols often rely on retinoic acid (RA), which can lead to limited stability of neuronal-like phenotypes over time. In this study, we evaluated a differentiation approach combining RA with a laminin-rich extracellular matrix (LrECM). This approach accelerated differentiation, with neuron-like morphology and neurite outgrowth observed as early as 4 days and sustained features for up to 10 days. Immunofluorescence analysis indicated increased NeuN expression, and Western blot confirmed the sustained presence of β3-tubulin during differentiation. Furthermore, a trend toward enhanced acetylcholinesterase (AChE) activity suggested partial cholinergic features. Altogether, these findings indicate that incorporating LrECM supports the stability of RA-induced neuron-like characteristics in SH-SY5Y cells and may provide a useful alternative for studies of neuronal-phenotype differentiation.

PMID 42543738
阅读全文 →
PubMedZhongguo shi yan xue ye xue za zhi2026-08-03

[The Clinical Significance and in vitro Experimental Study of hnRNP U in Multiple Myeloma].

Qi Wen-Hui WH, Xu Chun-Li CL, Zhang Li-Li LL, Tang Kou-Kou KK et al.

To analyze the expression level of heterogeneous nuclear ribonucleoprotein U (hnRNP U) and its correlation with prognosis in patients with multiple myeloma (MM), and explore the functional role as well as molecular mechanism of hnRNP U, thereby providing a theoretical basis for development of hnRNP U as a novel therapeutic target for MM. Based on Gene Expression Omnibus (GEO) database, the expression of hnRNP U in plasma cell diseases and healthy controls was compared. Based on the GSE9782 dataset (n =264), patients were divided into high expression group (n =114) and low expression group (n =150) according to the median expression level of hnRNP U . Overall survival (OS) between the two groups was compared. RPMI 8226, NCI-H929 and MM.1S cell lines were selected as tool cell lines. Following knockdown of hnRNP U by shRNA, the cell proliferation was detected by CCK-8. The apoptosis of MM cells was analyzed by Annexin V/7-AAD staining, and cell cycle was detected by BrdU/DAPI staining followed by flow cytometric analysis. The effect of hnRNP U on the biological characteristics of human MM cells was explored. The effect of knockdown of hnRNP U on DNA damage response pathways was analyzed by Western blot. Analysis of GSE5900 and GSE2113 datasets showed that the mRNA level of hnRNP U rose with the increased degree of malignancy of plasma cell diseases. Survival curve analysis of GSE9782 dataset showed that the high expression group of hnRNP U had a shorter OS than that of the low expression group. Down-regulation of hnRNP U in MM cell lines RPMI 8226, NCI-H929 and MM.1S could inhibit the cell proliferation, promote cell apoptosis and arrest the cell cycle. After knocking down hnRNP U, the expression levels of cleaved PARP and p-H2A.X, as the important markers of activated DNA damage pathway, were significantly increased in MM cells. hnRNP U is highly expressed in several plasma cell diseases including MM, and the high expression of hnRNP U in MM patients predicts poor prognosis. Knocking down hnRNP U can inhibit the malignant progression of MM cells, which is possibly associated with aggravated DNA damage.

PMID 42544663
阅读全文 →
PubMedJASA express letters2026-08-03

Visual identification of Taiwan Mandarin rounded vowels.

Chiu Chenhao C

While auditory and visual cues jointly support vowel perception, the role of visual information alone in vowel identification remains understudied. This study examines how Taiwan Mandarin speakers identify rounded vowels using visual-only input. Results reveal an asymmetric pattern between /y/ and /u/, with a bias toward /u/ as the default rounded vowel and greater difficulty identifying /y/. Signal detection analyses further indicate a higher response criterion for /y/. This default preference for /u/ appears to reflect phonological distributions in the language or a universal preference for the more peripheral vowel. Varying degrees of visual input did not modulate identification strategies, and visual information provided only limited support for distinguishing between /u/ and /y/.

PMID 42545149
阅读全文 →
PubMedAnnals of surgical oncology2026-08-03

ASO Visual Abstract: Comparison Study of Inverted-Nipple Ureteroneocystostomy and Direct Anastomosis in U-Shaped Orthotopic Neobladder Reconstruction.

Xing Qi Q, Wei Yang-Bing YB, Wang Xin X, Hao Hai-Feng HF et al.

PMID 42545421
阅读全文 →
PubMedMolecular biology reports2026-08-03

Upregulation of paraoxonase-2 enzyme in human osteosarcoma and its involvement in mechanisms promoting the aggressive behavior of tumor cells.

Gerini Eleonora E, Pompei Veronica V, Cecati Monia M, Campagna Roberto R et al.

Osteosarcoma (OS) is the most common bone cancer, known for its aggressive nature, high chemoresistance, and strong metastatic potential responsible for poor clinical outcomes. In this context, identifying reliable biomarkers and therapeutic targets is therefore critical. This study investigates the role of paraoxonase-2 (PON2), an intracellular enzyme known for its anti-oxidative and anti-apoptotic properties. PON2 overexpression has been observed in various cancers and is implicated in tumor development and progression. PON2 expression was evaluated by immunohistochemistry in bone tissue samples from OS patients and control subjects. shRNA-mediated PON2 silencing was performed in U-2 OS and Saos-2 cells to assess proliferation, viability, migration, chemosensitivity, ROS production, apoptosis activation, glucose uptake, and GLUT1 expression. PON2 overexpression and N-acetylcysteine (NAC) pre-treatment in CDDP-treated U-2 OS cells were used as rescue approaches. Preliminary analyses showed markedly higher PON2 expression in OS than in control bone specimens. PON2 knockdown reduced proliferation, viability, and migration, while enhancing sensitivity to cisplatin (U-2 OS and Saos-2) and doxorubicin (U-2 OS only); these effects were reversed by PON2 upregulation. PON2 silencing also increased ROS levels and caspase expression, and impaired glucose uptake by reducing GLUT1 expression and intracellular glucose levels. Since NAC did not fully rescue these alterations, PON2 appears to sustain chemoresistance by affecting important mechanisms related to ROS detoxification, glucose metabolism, and anti-apoptotic signaling. Obtained data clearly illustrate the potential of PON2 as promising biomarker and molecular therapeutic target for human OS.

PMID 42545402
阅读全文 →
PubMedPhysical chemistry chemical physics : PCCP2026-08-03

Enhancing phonon thermal conductivity in the semiconducting electride Sc2C via interstitial lattice electrons.

Wu Yishuo Y, Chen Xiangchuan X, Tong Zhen Z

Sc2C is a recently synthesized novel semiconducting electride characterized by electrons residing in well-defined interstitial lattice sites rather than being localized within atoms. While extensive research has been carried out to explore its novel properties, such as reversible, high-capacity hydrogen storage and electrochemical storage, existing literature lacks a precise characterization of its electronic states and thermal transport mechanism, which is a critical prerequisite for a comprehensive understanding of its electronic properties. In this work, we investigate the phonon thermal conductivity (κ) of Sc2C by incorporating the Hubbard U correction to accurately describe its electronic structure using first-principles calculations and the linearized Boltzmann transport equation. We find that the Hubbard U correction significantly enhances κ compared to calculations performed without it. Moreover, we unveil a key competition mechanism: while the Hubbard U correction slightly suppresses four-phonon (4ph) lifetime, it drastically increases the three-phonon (3ph) lifetime. The competition between 3ph and 4ph scattering ultimately leads to the enhanced thermal conductivity. Additionally, the in-plane κ exhibits high sensitivity to boundary scattering at length scales below 200 nm. This work clarifies the role of electronic correlation in modulating the thermal transport properties of electride-based nanodevices.

PMID 42544463
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多SH-U-454